| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $217.8M | +92.3% |
| SG&A Expense | $62.6M | +72.7% |
| Operating Income | -$280.4M | -87.5% |
| Pre-tax Income | -$260.0M | -106.0% |
| Income Tax | $764K | — |
| Net Income | -$260.8M | -106.6% |
| EPS (Basic) | -$3.93 | -81.1% |
| EPS (Diluted) | -$3.93 | -81.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.7M | -56.6% |
| Short-term Investments | $972.6M | +152.9% |
| Current Assets | $1.13B | +55.9% |
| Total Assets | $1.14B | +55.9% |
| Current Liabilities | $54.0M | +69.8% |
| Total Liabilities | $72.0M | +126.1% |
| Stockholders' Equity | $1.07B | +52.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$185.1M | -85.5% |
| Investing Cash Flow | -$573.5M | -299.6% |
| Financing Cash Flow | $568.9M | +68.9% |